| Literature DB >> 26742052 |
Deniz Yeter1, Michael A Portman2, Michael Aschner3, Marcelo Farina4, Wen-Ching Chan5,6, Kai-Sheng Hsieh7,8,9, Ho-Chang Kuo10,11,12.
Abstract
Kawasaki disease (KD) primarily affects children <5 years of age (75%-80%) and is currently the leading cause of acquired heart disease in developed nations. Even when residing in the West, East Asian children are 10 to 20 times more likely to develop KD. We hypothesized cultural variations influencing pediatric mercury (Hg) exposure from seafood consumption may mediate ethnic KD risk among children in the United States. Hospitalization rates of KD in US children aged 0-4 years (n = 10,880) and blood Hg levels in US children aged 1-5 years (n = 713) were determined using separate US federal datasets. Our cohort primarily presented with blood Hg levels <0.1 micrograms (µg) per kg bodyweight (96.5%) that are considered normal and subtoxic. Increased ethnic KD risk was significantly associated with both increasing levels and detection rates of blood Hg or cadmium (Cd) in a linear dose-responsive manner between ethnic African, Asian, Caucasian, and Hispanic children in the US (p ≤ 0.05). Increasing low-dose exposure to Hg or Cd may induce KD or contribute to its later development in susceptible children. However, our preliminary results require further replication in other ethnic populations, in addition to more in-depth examination of metal exposure and toxicokinetics.Entities:
Keywords: Kawasaki disease; allergy; autoimmunity; infantile acrodynia; mercury; methylmercury; pediatrics; pollution; seafood; toxicology
Mesh:
Substances:
Year: 2016 PMID: 26742052 PMCID: PMC4730492 DOI: 10.3390/ijerph13010101
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
KID and NHANES cohort sample sizes and weighted ethnicity in U.S. children.
| Ethnicity | KID (1997–2006) 1 | NHANES (2011–2012) 2 | U.S. Census (2012) 3 |
|---|---|---|---|
Notes: Age 0 to 4 years; Age 1 to 5 years; Age 0 to 18 years (children born in 1994–2012).
Kawasaki disease hospitalizations per 100,000 U.S. children aged 0 to 4 years.
| Ethnicity | Averaged (OR) | 1997 (OR) | 2000 (OR) | 2006 (OR) |
|---|---|---|---|---|
| 18.0 (0.97) | 16.9 (0.96) | 19.7 (1.15) | 17.5 (0.84) | |
| 33.9 (1.83) | 32.5 (1.85) | 39.0 (2.28) | 30.3 (1.46) | |
| 10.8 (0.58) | 9.1 (0.52) | 11.4 (0.67) | 12.0 (0.58) | |
| 13.5 (0.73) | 11.1 (0.63) | 13.6 (0.80) | 15.7 (0.75) | |
| n/a | n/a | n/a | n/a | |
Note: Excluded from analyses as a result of low KD reporting.
Average, minimum, and maximum values for blood cadmium, mercury, manganese, lead, and selenium in U.S. children aged 1 to 5 years.
| Ethnicity | Cd µg/L 2 (OR) | Hg µg/L 2 (OR) | Mn µg/L 3 (OR) | Pb µg/dL 4 (OR) | Se µg/L 5 (OR) |
|---|---|---|---|---|---|
| [min–max] | [min–max] | [min–max] | [min–max] | [min–max] | |
| 0.13 (1.00) | 0.50 (1.39) | 165.25 (0.99) | |||
| [0.11–0.43] | [0.11–18.89] | [4.83–17.49] | [0.29–18.37] | [110.24–217.25] | |
| 165.00 (0.98) | |||||
| [0.11–0.39] | [0.11–5.18] | [5.94–25.42] | [0.29–3.26] | [102.34–204.90] | |
| 10.86 (0.98) | 1.59 (1.12) | 169.22 (1.01) | |||
| [0.11–0.28] | [0.11–1.05] | [6.28–24.49] | [0.18–27.88] | [126.37–241.38] | |
| 0.13 (1.00) | 165.82 (0.99) | ||||
| [0.11–0.27] | [0.11–1.98] | [3.97–25.54] | [0.26–5.24] | [96.24–221.36] | |
| 0.13 (1.00) | 0.44 (1.22) | 11.58 (1.05) | 1.11 (0.78) | 166.73 (1.00) | |
| [0.11–0.22] | [0.11–4.57] | [4.84–21.94] | [0.44–3.14] | [126.95–202.08] | |
Notes: Excluded from analyses as a result of low KD reporting; Lower limit: 0.12 µg/L; Lower limit: 1.62 µg/L; Lower limit: 0.19 µg/dL; Lower limit: 96.25 µg/L; ANOVA testing for statistical significance between ethnicities Statistical significance: * p-value ≤ 0.05; ** p-value ≤ 0.01.
Blood values at or above detectable limits in US children aged 1 to 5 years.
| Ethnicity | Cd % (OR) 2 | Hg % (OR) 2 | Mn % 3 | Pb % (OR) 4 | Se % 5 |
|---|---|---|---|---|---|
| 20.2% (1.22) | 100% | 100% (1.01) | 100% | ||
| 100% | 100% (1.01) | 100% | |||
| 100% | 98.3% (0.99) | 100% | |||
| 19.9% (1.20) | 77.0% (1.00) | 100% | 100% (1.01) | 100% | |
| 22.5% (1.36) | 72.5% (0.94) | 100% | 100% (1.01) | 100% | |
Notes: Excluded from analyses as a result of low KD reporting; Lower limit: 0.12 µg/L; Lower limit: 1.62 µg/L; Lower limit: 0.19 µg/dL; Lower limit: 96.25 µg/L; ANOVA testing for statistical significance between ethnicities Statistical significance: * p-value ≤ 0.05; ** p-value ≤ 0.01.
Significant ethnic variation of KD risk in U.S. children accounted for by the r2 value from Pearson correlation tests.
| Elements | Average µg/L | Detection Rate | Bottom Percentile | Top Percentile |
|---|---|---|---|---|
| n/a 2,3 | ||||
| 22.5% | n/a 1 | 0.1% 3 | 21.0% 4 | |
| 40.4% | 28.3% | 0.8% 3 | 43.0% 5 | |
| 42.4% | n/a 1 | 12.6% 3 | 55.8% 4 |
Notes: 100% detection; No difference in values; 5th percentile; 95th percentile; 97.5th percentile; Statistical significance: * p-value ≤ 0.05; ** p-value ≤ 0.01.
Figure 1Blood mercury and ethnic Kawasaki disease risk. The logistic regression model for our initially identified association of increasing ethnic Kawasaki disease (KD) risk with higher average mercury (Hg) levels in the blood (p = 0.003) was also statistically significant (p < 0.001), and suggests Hg levels in the blood account for 93.6% of the ethnic variation in KD rates in a linear dose-responsive manner as demonstrated by the r2 value.